Virtuals Protocol stated that veVIRTUAL holders were originally planned to receive 20% of the total points allocation, but due to the "diamond hand reward" mechanism fluctuation, the daily actual allocation may temporarily be below this proportion. The project team indicated that this difference will be compensated the following day, with compensation for the first two days being issued in a lump sum, and subsequent adjustments will be settled daily to ensure fair distribution.
Virtuals Protocol updates veVIRTUAL points distribution mechanism, discrepancies below 20% will be compensated the next day
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.
